The UK-Rapid Test Consortium was set up by Abingdon Health to bring together scientists and medical technology manufacturers to be able to deliver millions of test kits as quickly as possible. By working together, some of the UK’s leading medical technology companies will deliver more volume more quickly to help fight Covid-19.
The UK Government supported the setup of the UK Rapid Testing Consortium and invested in the development of the rapid antibody tests.
The UK-RTC comprises Abingdon Health, the University of Oxford, Omega Diagnostics, BBI Solutions and CIGA Healthcare
AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
This simple to use lateral flow rapid test is CE marked for use by healthcare professionals. Using a blood sample from a finger-stick puncture results are available in 20 minutes.
- Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
- Sensitivity: 98.03%, Specificity: 99.56%*
- Minimal operator training required
- CE marked for use by healthcare professionals
- For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries
From a finger-prick sample of blood, AbC-19™ Rapid Test detects the SARS-CoV-2 IgG neutralising antibodies to the full spike protein produced in response to the virus or following vaccination. The test will determine if the body has produced a measurable immune response indicating a previous infection with COVID-19 virus or vaccination. It will not confirm if you are currently infected by the virus.